Devyser Diagnostics AB (OSTO:DVYSR) Debt-to-Equity : 0.18 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Debt-to-Equity?

Devyser Diagnostics AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr16.0 Mil. Devyser Diagnostics AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr52.3 Mil. Devyser Diagnostics AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr374.5 Mil. Devyser Diagnostics AB's debt to equity for the quarter that ended in Mar. 2024 was 0.18.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Devyser Diagnostics AB's Debt-to-Equity or its related term are showing as below:

OSTO:DVYSR' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.14 Max: 0.7
Current: 0.18

During the past 7 years, the highest Debt-to-Equity Ratio of Devyser Diagnostics AB was 0.70. The lowest was 0.03. And the median was 0.14.

OSTO:DVYSR's Debt-to-Equity is ranked better than
60.1% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs OSTO:DVYSR: 0.18

Devyser Diagnostics AB Debt-to-Equity Historical Data

The historical data trend for Devyser Diagnostics AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Debt-to-Equity Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.65

0.70

0.03

0.05

0.19

Devyser Diagnostics AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial												0.05	0.18	0.19	0.19	0.18

Competitive Comparison of Devyser Diagnostics AB's Debt-to-Equity

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devyser Diagnostics AB's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Debt-to-Equity falls into.

Devyser Diagnostics AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Devyser Diagnostics AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(17.5	+	57.3)	/	385.1
	=	0.19

Devyser Diagnostics AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(16	+	52.3)	/	374.5
	=	0.18

Devyser Diagnostics AB (OSTO:DVYSR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Devyser Diagnostics AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB (OSTO:DVYSR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Instrumentvagen 19, Hagersten, SWE, 126 53

Website

https://www.devyser.com

Devyser Diagnostics AB is specialized in the development, manufacture and sale of market-leading genetic diagnostic kits.The products are used for complex DNA testing in the hereditary disease, oncology and post-transplantation monitoring fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB (OSTO:DVYSR) Headlines

No Headlines